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A B S T R A CT 
Polymer blend made from poly(E - caprolactone)/chitosan (PCL/CHT) offers interesting opporttmities for bio­
logical applications. The paper presents a new way to fabricate PCL/CHT double-porosity (macrovoids with 
interconnected microporosity) membrane materials from a chemical optimiz.ation of the solvent and non-solvent 
phases and from a moclified phase inversion technique. By varying the PCL/CHT proportion, it is shown that it is 
possible to improve the chemical and physical properties of the CHT carbohydrate polymer. The PCL/CHT 
membranes are fully characterized in term of physico-chemical properties (ATR-FTIR, XRD and DSC) to tm­
derstand the miscibility of the two-polymer blend. Morphological characterization by SEM shows that by in­
creasing CHT wt% in the blend, the size of the macrovoids was increasing. Rapid enzymatic degradation of PCL 
from ail the blend was found by using lipase (from P. cepacia). The mechanisms at the origin of the morpho­
logical structuration of the material is also discussed. To test the ability to operate these materials as small 
cliameter vascular scaffolds, cell culture with human umbilical vein endothelial cells (HUVECs) were carried out 
on the membrane and the results analyzed with laser scanning confocal microscopy (LSCM). Data suggest that 
the blend membrane with higher concentration of CHT polymer wt% have suitable properties that promote high 
number of cells on the surface by maintaining cellular cytoskeleton integrity within 3 days. The blend membrane 
with a double porous morphology could be potentially applicable in future for small cliameter vascular graft 
application. The surface macrovoids (20-90 µm) could be useful for three-dimensional cellular adhesion and 
proliferation and interconnected microporous spongy network (7-20 µm) is expected to transfer essential nu­
trients, oxygen, growth factor between the macrovoids and the supernatant. 
Tissue engineering relies on the use of artificial degradable porous 
material scaffold integrated with biological cells or molecules to re­
generate tissues [1]. The scaffold material should offer specific func­
tionalities to accomplish this goal. Severa! studies show that 3D struc­
tures of the support material control the cell growth [2]. The material 
composition is a key point that controls the biocompatibility, the cell 
adhesion and optionally the biodegradability. The material engineering 
must be tailored to the biological strategy. In recent studies, artificial 
vascular grafts generally have been fabricated from synthetic polymers, 
such as polyester, e.g. polycaprolactone (PCL) or polylactic acid (PLA) 
or polylactic-co-glycolic acid (PLGA) or polyurethane [3,4]. This kind 
of polymer scaffolds can pro'l'ide sufficient mechanical strength and are 
considered biocompatible and biodegradable without any toxic by­
products. However, they are hydrophobie in nature and Jack reactive 
functional sites for further bio-functional modification [5] which led to 
the development of innovative hybrid materials by mixing both syn­
thetic and natural polymers [6]. Natural carbohydrate polymers like 
chitosan (CHT) on the other hand can provide an excellent candidate 
for biomedical vascular grafts application, mostly in combination with 
other synthetic polymers [7-11]. CHT is a linear polysaccharide com­
posed of glucosamine and N-acetyl glucosamine units connected 
through ft-1,4-glycosidic bond and produced from the highly abundant 
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• Corresponding author. Laboratoire de Génie Chimique, Université de Toulouse, CNRS, INPT, UPS, Toulouse, France. 
E-mail address: patrice.bacchin@univ-tlse3.fr (P. Bacchin). 
observed by SEM and the physico-chemical properties of the blends
were characterized by ATR-FTIR mapping, XRD and DSC. In addition,
enzymatic degradation study was performed by using lipase (from
Pseudomonas cepacia; 7U/ml) at 37 °C in phosphate buffer saline (PBS)
at physiological pH. Change in morphological properties and weight
loss (%) were monitored at predetermined time intervals of the de-
gradation study. To test the biocompatibility and potentialities of the
membranes as a small diameter vascular graft for cardiovascular system
disease, cell culture was performed with human umbilical vein en-
dothelial cells (HUVECs) up to 3 days and results were observed in laser
scanning confocal microscopy.
2. Materials and methods
2.1. Materials
CHT (MW 190–310 kDa, 75–85% de-acetylation degree, CAS
Number 9012-76-4) was purchased from Sigma-Aldrich and PCL (MW
80 kDa, CAPA™ 6800, CAS Number 24980-41-4) was purchased from
Perstorp Holding AB, Sweden. Isopore® Polyester (PET) track-etched
membranes (with 10 μm pore diameter), used as macrovoid generator,
were purchased from Sterlitech, USA. Acetic acid, formic acid, sodium
hydroxide and sodium azide (NaN3) were purchased from Sigma-
Aldrich. Lipase from Pseudomonas cepacia (activity: 35U/mg, CAS
Number 9001-62-1) were purchased from Sigma-Aldrich. Phosphate
buffer saline (PBS) was purchased from Fisher Scientific (CAS Number
7778-77-0). Human umbilical vein endothelial cells (HUVECs) were
purchased from Lonza and the corresponding culture medium (EGM-2:
basal medium with supplement mix, CC-22011) was obtained from
Promocell. Collagen I (rat-tail) were obtained from Santa Cruz. Trypsin-
EDTA, Formaldehyde, 6-Diamidino-2-Phenylindole (DAPI), and Alexa
Fluor 488 Phalloidin were purchased from Thermo Fisher. Triton X-
100, bovine serum albumin (BSA) were purchased from Sigma Aldrich.
2.2. Methods
2.2.1. Development of the membrane with a double porosity level
The membranes were developed by modified liquid induced phase
inversion method by diffusion between a solvent as formic acid/acetic
acid (FA/AA) mixture and non-solvent as NaOH aqueous solution. PCL
and CHT with a ratio 100/0, 90/10, 80/20 and 70/30 (w/w%) were
dissolved in FA/AA (w/w%) mixture. The polymer concentration in the
solution was expressed in wt.% as followed:
= +CHT(wt. %) 100 MassMass MassCHTCHT PCL (1)
= ++ +Polymer(wt. %) 100 Mass MassMass Mass MassCHT PCLCHT PCL Solvents (2)
The polymer solution was casted on a glass plate using a casting
knife in order to achieve a thickness around 250 μm at 23 °C. The track-
etched membrane was at first immersed in the solvent mixture to fill the
pores with solvent mixture, slowly wiped out to remove excess solvent
and slowly applied on the casted polymer solution (Fig. 1).
The glass plate was then gently immersed in a non-solvent bath
containing NaOH solution at 23 °C. Immediately after the immersion,
demixing via neutralization of the acidic casted solution was started
due to solvent exchange leading to the flat sheet membrane formation
in few minutes (in case of PCL/CHT 100/0) to hours (in case of PCL/
CHT 70/30). It should be noted that this quenched phase inversion
method leads to a thermodynamically non-equilibrium state of the
polymers in the final membrane and two different kinds of porous
structures were formed in the same condition Fig. 1.
The solvent exchange rate was spatially quite homogeneous where
the polymer solution was not covered by the track-etched membrane
leading to single porous structure without enough open pores on the top
natural polymer, chitin. It is biocompatible, bioresorbable, hydrophilic 
and non-toxic. It has high affinity towards proteins and provides anti-
bacterial, hemostatic, fungistatic, antitumor and anticholesteremic 
properties [12–16]. It can provide a favorable environment for cell 
attachment as chemical structure of CHT is similar to glycosaminogly-
cans (GAGs), which are native components of extracellular matrix 
(ECM) [17,18]. However, it has low mechanical properties in wet 
conditions and high hydrophilicity, which can be easily optimized by 
blending with synthetic polymers. Blending can also improve the low 
degradation rate of the synthetic polymers in physiological conditions. 
It is well accepted that blending these two kind of polymers will be very 
advantageous, which can significantly reduce all the disadvantages and 
combine the benefits of the individual polymers providing a  superior 
material with good tissue compatibility and sufficient mechanical 
strength [19–21]. The 3D structure of the material should enable to 
host the cells but also to distribute the nutrients and to favor the re-
moval of cellular metabolic products.
In the last decades, various scaffolds h ave b een d eveloped more 
often from an assembly of simple fibers. The study of PCL/CHT blend 
with electrospinning method is extensively researched and well adap-
table for better cell attachment with good dynamic properties 
[9,10,12,19–25]. However numerous studies report on the difficulties 
encountered for electrospinning pure chitosan as the structure is me-
chanically weak, limiting practical processing [26–29]. Furthermore, it 
is difficult to manage the multiple functionality requirements with an 
assembly of fibers. The u se o f membranes a ppears a s a n interesting 
alternative to tune the porosity and to manage the mass transport 
properties. The different level of membrane porosity can be adjusted in 
order to have both macrovoids to host the cells and interconnected 
micropores network to ensure the transportation of molecules [30]. 
Solvent mixing with PCL and CHT was more conveniently used com-
pared to melt blending which is quite difficult to perform as CHT de-
composes before undergoing melting. Although it is also difficult to 
make a homogeneous blend in solvent mixing due to the high viscosity 
of CHT in solvent and also the scarcity of good mutual solvents. Several 
efforts were made as Honma et al. [25,31] produced PCL/CHT blend 
casting by using common solvent as 1,1,1,3,3,3-hexa-fluoro-2-propanol 
(HFIP) solution. They showed that PCL/CHT can be processed by using 
HFIP but this solvent is very expensive, carcinogenic and difficult to 
remove during washing [32]. Although a different approach was re-
ported to find a good mutual solvent [33–38]. Among them a suitable 
approach could be to dissolve CHT in 0.5 M acetic acid and PCL in 
glacial acetic acid where the authors [35] were able to obtain a mixture 
of these two solutions at a low concentration of polymer but it was not 
effective at high concentration [31] as in our case. In another study, a 
solvent mixture of formic acid/acetone was reported to be used to de-
velop PCL/CHT nanofibers at high concentration of polymers. In this 
case, it was forming beads-like morphology indicating incomplete dis-
solution of the polymer [39]. Recently, formic acid/acetic acid mixture 
[40] with certain ratio has produced a mutual solvent for both polymers 
with minimal degradation and phase segregation but with faster dis-
solution. Despite so many combination of solvents, the author [40] 
have reported that the formic acid/acetic acid mixture produced the 
bead free and least toxic scaffold and the solvent can be easily removed 
during washing.
Here we propose a new scaffold b ased o n p olymer membrane 
technologies to meet the needs and the constraints discussed above. The 
main objectives are to obtain a biocompatible and biodegradable ma-
terial with open macrovoids for three-dimensional cell culture and in-
terconnected microporosities to transport nutrients, oxygen, between 
the macrovoids and supernatant. The membranes were fabricated from 
a P CL/CHT blend with a modified l iquid i nduced p hase inversion 
technique in order to create macrovoids on the surface. The percentage 
ratio of P CL/CHT (100/0, 90/10, 80/20, 70/30 w/w %) blend was 
changed to investigate a range of chemical interactions, miscibility and 
biodegradability. The morphology of the developed materials was
surface. On the other hand, where the polymer solution was covered by
the track-etched membrane, a heterogeneous solvent exchange was
occurred leading to the formation of double porous structure. The
macrovoids were formed where the non-solvent has a direct access to
the polymer solution through the pores of the track-etched membrane.
And, interconnected micropores were formed by diffusion of the non-
solvent through the newly formed macrovoids. This mechanism was
described by Strathmann et al. [41] to explain the formation of skinned
membrane with macrovoids and sponge structure; the nascent skin
playing an equivalent role like our track-etched membrane as discussed
in Sec. 3.7.
After the membrane formation, when it turned opaque and detached
from the glass plate, the track-etched membrane was removed gently.
The PCL/CHT membrane was washed several times in ultrapure water
and stored in ultrapure water at 4 °C.
The surface where the macrovoids were open towards the non-sol-
vent (i.e. where the track-etched membrane was applied) is denoted as
top surface and the other surface, which was facing the glass plate, is
denoted as the bottom surface.
2.2.2. Viscosity measurements of the polymer solution
The viscosity of the polymer solution was measured by Rheometer
Anton Paar Physica MCR 301, France (Fig. 2). After complete dissolu-
tion of the solution, a 0.6ml volume was injected on a cone plate
rheometer (diameter 50mm). The viscosity was measured at a shear
rate from 2 to 100 s−1 at 20 °C. All the measurements were performed
inside a close chamber in order to avoid the solvent evaporation and
dissolution of water from air moisture.
2.2.3. Scanning electron microscopic (SEM) analysis
SEM analysis (Phenom XL, Fondis Biotech, France) were done on
both double and single porous membranes to evaluate all the developed
blend morphology from the top surfaces and the cross sections (Fig. 3).
All the samples were coated with gold and analysis were performed
at an accelerating voltage of 10 kV. The surface porosity was also de-
termined from the SEM images by using ImageJ [42] software and re-
ported in Table 1.
2.2.4. Attenuated total reflection (ATR)-Fourier transformed infrared
(FTIR) spectroscopic analysis and mapping
FTIR analysis were done by using a Nexus Nicolet (USA) FTIR
Microscope system with an ATR diamond crystal at 45° angle (Fig. 4).
Prior to the examination, 1 cm2 sample was cut and measurements were
done on both surfaces (three times) of each sample. Each point was
scanned sixteen times with a resolution of 8 cm−1 and the spectral
range was 650–4000 cm−1. The ATR correction was applied on all the
Fig. 1. Double porosity development by modified liquid induced phase inver-
sion process with the following steps: PCL/CHT membrane casting, applying the
track-etched membrane before immersing in non-solvent bath and removing
track-etched membrane after membrane formation. SEM images of PCL/CHT
100/0 represent double porosity and single porosity on top surface and cross
section of the same membrane.
Fig. 2. Viscosity [Pa.s] vs shear rate [1/s] measurement of PCL/CHT 100/0
(15wt%), PCL/CHT 90/10 (14wt%), PCL/CHT 80/20 (14wt%), PCL/CHT 70/
30 (10wt%) and PCL/CHT 0/100 (4 wt%) scaffolds respectively in solvent FA/
AA mixture.
spectra [43]. FTIR chemical mapping on either side of the membrane
also performed using an infrared spectrometer IN10MX Thermo-
scientific (USA) with an ATR germanium crystal of a 25° angle (Fig. 5).
A square sample of 6mm2 was studied. Data were analyzed on a
50 μm×50 μm surface for each point (one point was measured every
50 μm) with a spectral resolution of 8 cm−1. Each measurement was
scanned by sixteen times with the spectral range 650–4000 cm−1.
2.2.5. X-ray diffraction (XRD) analysis
The crystalline structure of membrane sample (5mm × 5mm) was
investigated by XRD analysis using a D4 Endeavor X-ray diffractometer
(CuKα1= 0.154056 nm and CuKα2= 0.154044 nm; generator 40 eV;
40mA, Bruker AXS, Karlsruhe, Germany) from 10° to 100° at a scan
speed of 21.7 s/step that is equal to 0.02° (2-theta) as can be seen in
Fig. 6(A).
2.2.6. Differential scanning calorimetric (DSC) measurements
DSC experiments were conducted (DSC TA instrument Q2000,
France) in order to evaluate thermal properties of the PCL/CHT blend
membranes (Fig. 6(B)). The membranes were dried at 37 °C and were
cut in a dimension of 3mm2. The sample was put inside an aluminum
pan and mechanically covered by an aluminum cap. The pre-weighted
aluminum pan was placed inside the DSC machine and equilibrate at
20 °C. The temperature scanning was performed at a constant heating
rate of 10 °C min−1, from 20° to 80 °C without preheating step. The
melting point (Tm) of PCL in the blend by varying CHT wt.% (pure PCL
melting point is 60 °C) determined.
2.2.7. Enzymatic degradation of the blend
The membranes were dried in vacuum at 37 °C until constant weight
was reached and were cut in 6mm × 6mm pieces. The initial weight
(wi) was taken (in mg up to the fifth decimal point). Then the samples
were placed in a 5ml vials containing 3ml of PBS 1× solution, 0.6mg
(7U/ml) of lipase (from Pseudomonas cepacia) and 0.05wt% NaN3. The
entire procedure was done in a sterile condition and vials were sealed
and stored in incubator at 37 °C. The enzyme solution was changed
every day in order to maintain the same enzymatic activity during the
whole process. The same procedure was done without the enzyme as a
control. Three consecutive samples were taken out after 6 h of in-
cubation and every one-day intervals until 10 days. The samples were
washed with copious deionized water, dried at 37 °C in vacuum until
constant weight. The final weight, Wf , was taken.
The weight loss, W %loss , was calculated by the following equation






where, Wi , is the initial weight and, Wf , the final weight.
Scanning electron microscopic images of the degraded membranes
(Fig. 9) were taken and the ageing solution was collected to observe the
change in pH (Fig. 8(B)).
2.2.8. Cell culture and study by laser scanning confocal microscopy
Membranes were cut with diameter of 2.2 cm and washed with
sterile phosphate-buffered saline (PBS) three times. The samples were
put in 12 well plate and kept in sterile PBS suspension at 4 °C for
overnight before the cell seeding. Then the samples were washed again
with sterile PBS, 1ml collagen I (0.1mg/ml in PBS) was added in the
well plate and incubated for 30min at 37 °C. Then the well plate was
taken out from the incubator, washed with PBS and incubated for 1 h
Fig. 3. SEM micrographs of membranes on the top surface and cross section
with double porosity (using track-etched membrane): (A, B) PCL/CHT 100/0,
(C, D) PCL/CHT 90/10, (E, F) PCL/CHT 80/20, (G, H) PCL/CHT 70/30. Single
porosity (without using track-etched membrane): (I, J) PCL/CHT 100/0, top
surface and cross-section, respectively.
Table 1
Summary of the polymer blend membrane properties with distinct concentra-
tion in correlation with viscosity and pore diameter, melting point.
PCL/CHT percentage Ratio
100/0 90/10 80/20 70/30 0/100
Total Polymer Conc. (w/w%) 15 14 14 10 4
Solvents HCOOH/AcOH (w/w%) 70/30 60/40 60/40 50/50 50/50
Nonsolvent NaOH (M) 0.3 0.5 0.5 0.5 –
Macrovoid diameter (μm)a 20 ± 3 56 ± 5 67 ± 5 90 ± 5 –
Micropore diameter (μm)a 7 ± 3 7 ± 3 7 ± 3 20 ± 5 –
Surface Porosity (%)a 40 ± 5 50 ± 5 53 ± 5 45 ± 5 –
Viscosity of polymer sol. (Pa.s) @
shear rate 2 sec-1 b
0.153 0.293 0.987 0.338 3.89
M.P. of PCL in the Blend (Tm) oC c 61.59 62.78 63.19 61.70 –
a Data were obtained by ImageJ software.
b From Fig. 2.
c From Fig. 6B.
with EGM-2 culture medium (Lonza). Meanwhile, human umbilical
vein endothelial cells (HUVECs from Lonza) were trypsinized (passage
4) and collected from a confluent T175 flask. The well plate was taken
inside a sterile hood and the incubated culture medium was discarded.
Then, 3ml of homogeneous cell suspension (4×106 cells/ml or
106 cells/cm2) was pipetted in each well plate and incubated at 37 °C
for 2 h to ensure complete attachments. The well plate was taken out of
the incubator, replaced with fresh culture medium to remove non-at-
tached cells and incubated again.
After 3 days, the well plates were taken in sterile hood and prepared
for cell staining. At first the well plates were washed with PBS and the
cells were fixed by adding 4% formaldehyde for 15min. Then the wells
were washed with PBS and kept in a permeabilization buffer (PB; 9:1
v:v ratio of 11mg/ml BSA with 1% Triton X-100 in PBS) at room
Fig. 4. (A) ATR-FTIR spectra of PCL/CHT scaffold on bottom surface where; PCL/CHT 100/0 in red, PCL/CHT 90/10 in green, PCL/CHT 80/20 in purple, PCL/CHT
70/30 in blue and CHT crude in cyan color respectively. (B, C & D) ATR-FTIR spectra of PCL/CHT 90/10, 80/20 & 70/30 scaffold respectively on either side of same
membrane where; top surface in red and bottom surface in blue color respectively. (For interpretation of the references to color in this figure legend, the reader is
referred to the Web version of this article.)
Fig. 5. Chemical mapping of PCL/CHT blends on either surface on the same membrane where; C=O for PCL observed at 1726 cm−1 and hydrogen bonded N–H and
O–H observed at 3364 cm−1. Red and blue colors indicate the intensity of the corresponding bands, high and low intensity, respectively, corresponding to high and
low concentration. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
temperature for 15min to block any non-specific protein-binding sites.
Phallodin-488 and DAPI (Actin Green 488, NucBlue, Thermo Fisher
Scientific) were added together in the concentration of 1 drop/ml and
1:4000 in PB, respectively, and incubated at room temperature for 1 h.
To prevent photo-bleaching, the well plates were protected from light
exposure from this step onwards. Then the well plates were washed
thoroughly with PBS and imaged with confocal microscopy (Zeiss LSM
510, Nikon) in 20× and 60×magnification (Fig. 12.). As supple-
mentary information, other biological characterizations have been
performed with human mesenchymal stem cells (MSCs) in a successive
z-stack confocal analysis on these 3D scaffolds [44] and the hydraulic
permeability of HUVECs layers have been measured in a microfluidic
organ-on-chip device [44,45].
3. Results and discussion
3.1. Polymer-solvent-non solvent optimization
Chitosan (CHT) and polycaprolactone (PCL) are polymers with very
different chemical properties and finding a common solvent to develop
a membrane was an important challenge. Moreover, maintaining an
Fig. 6. (A). X-ray diffraction spectra for the different blends, (B) Differential scanning calorimetric study of blends as a function of PCL content in the blend.
Fig. 7. Nishi – Wang plot. Where Tm and Tm2 are the equilibrium melting
temperature (K) of the blend and pure PCL, respectively, and Ψ2 is the volume
fraction of PCL in the blend.
optimum viscosity was very important to achieve the double porous
membrane structure. The solvent optimization have been partially
based on viscosity measurement of the polymer casted solution (Fig. 2)
as it was an important parameter that directed the size of the macro-
voids during solvent exchange. During solvent mixing, a visible re-
duction of the viscosity has been observed by dissolving PCL in the
common solvent after 2–3 h at temperature more than 35 °C, probably
due to the hydrolysis of ester bonds of PCL. In order to avoid the re-
duction of viscosity, different factors were tuned. CHT was dissolved in
the solvent mixture at first at 55 °C for 12 h and then PCL was added
when the temperature was below 35 °C. In the common solvent, formic
acid was found more responsible for the breakage of PCL ester bonds,
although higher wt% of formic acid was better for faster and bead free
dissolution. For these reasons, the solvent was also optimized for each
PCL/CHT polymer blend according the following composition: PCL/
CHT 100/0 (15wt%) in FA/AA 70/30 (w/w) %, PCL/CHT 90/10 and
80/20 (14wt%) in FA/AA 60/40 (w/w) % and PCL/CHT 70/30 (10wt
%) in FA/AA 50/50 (w/w) % (Table 1). In these conditions of com-
position and temperature, a clear, light yellow and viscous solution was
obtained within 2 h. After this dissolution step, the polymer solution
was kept in stand for 10–20min before starting the membrane casting.
Due to high viscosity of CHT in the solvent mixture, PCL/CHT blend
beyond 70/30 ratio was not successful as it was difficult to make a
homogeneous mixture of polymer solution by mechanical stirrer and to
avoid phase segregation between the two polymers. Viscosity of CHT
was remarkably high in the solvent mixture (Fig. 2) that dissolving pure
CHT above 4wt% was difficult and concentration lower than 4wt% are
not sufficient to make a double porous membrane certainly due to lack
of good entanglement between the polymer chain or a phase inversion
leading to polymer particles.
The viscosity of the final polymer solution of pure PCL, CHT and the
different blends were measured and reported in Fig. 2. Results showed
that the viscosity of pure CHT of only 4 wt% solution was significantly
higher than the viscosity of PCL/CHT 100/0 of 15wt% solution in the
common solvent. This was due to several factors. First of all, the mo-
lecular weight of CHT (190 kDa–310 kDa) was higher than the mole-
cular weight of PCL (80 kDa). Secondly, CHT has higher affinity to-
wards the solvent due to the presence of stronger secondary interaction
between the functional groups of CHT and the common solvent. As a
result, CHT polymer chains likely to be deployed in the solvent leading
to higher viscosity [46]. On contrary, in acidic solvent, the viscosity of
PCL could be decreased to some extent due to a decrease of the polymer
chain length via breakdown of ester linkages. All these effects are re-
sponsible for the high difference of solution viscosity between these two
polymers.
Concerning the non-solvent, concentration of NaOH more than
0.5M in the non-solvent bath was responsible to make the membrane
fragile by breaking the ester bonds in PCL during membrane formation.
Concentration lower than 0.2M was not sufficiently concentrated to
allow the formation of macrovoids. We also varied the concentration of
the NaOH solution depending upon the viscosity of the casted solution
in order to get consistent macrovoids height of about 50–70% of the
total membrane thickness. Finally, a 0.3M NaOH solution was used for
PCL/CHT 100/0 (15wt%) and 0.5M NaOH solution was used for the
rest of the PCL/CHT blend.
3.2. Morphology of the double porous membrane
After the membrane fabrication, the top surface and the cross sec-
tion morphological characteristics were observed in SEM (Fig. 3). All
the scaffolds, which were produced by using the track-etched mem-
brane, are showing double porosity where the macrovoids are open
towards the top surface and connected with the spongy microporous
network. From the cross section view, it was observed that the localized
arrival of the non-solvent inside the polymer solution were creating the
macrovoids which were increasing by increasing CHT wt.%. The mac-
rovoids diameter were around 20 ± 3–90 ± 5 μm and the diameter of
interconnected micropores were around 7 ± 3 μm (except the PCL/
CHT 70/30 ratio for which the micropore diameter was 20 ± 5 μm
(Table 1)).
3.3. Chemical characterization by ATR-FTIR spectra
The representative FTIR spectra of the bottom surface of the mem-
brane are shown in Fig. 4 (A). All the stretching and bending vibrations
are found to be well matching with the reported values [31]. In crude
CHT, the broad peak at 3364 cm−1 was found due to stretching vi-
bration of intramolecular hydrogen bonding between N–H and O–H.
The peak at 2880 cm−1 was due to the asymmetric bending of C–H
group. The N–H and C–O–C peaks were observed at 1651 cm−1 and
1070 cm−1 respectively. In PCL, the peaks at 2946 cm−1 and
1726 cm−1 represent the characteristic peaks for C–H and ester
Fig. 8. (A) Weight loss % of the sample with lipase enzyme (Pseudomonas ce-
pacia; 7 U/ml) at different time intervals, (B) pH of the enzyme degraded so-
lution after the study and (C) weight loss % of the sample without enzyme after
90 days.






















Fig. 9. SEM images of degraded PCL/CHT blends after 6 h, 1 day and 10 days with lipase enzyme (Pseudomonas cepacia; 7 Ulm!) and after 90 days without enzyme. 
carbonyl (C=O) groups respectively. In PCL/CHT blend, by decreasing 
CHT proportion, the stretching vibration of intramolecular hydrogen 
bonding between N-H and 0-H, shifted towards higher wavenurnber 
region from 3364 cm - l in PCL/CHT 70/30 to 3437 cm - l in PCL/CHT 
90/10. In addition, the C-H stretching of PCL shifted also towards 
higher wavenurnber region from 2943 cm -l in PCL/CHT 70/30 to
2946 cm -l in PCL/CHT 90/1 O. From ail these results, no additional
peak was observed indicating presence of no covalent bonding between 
the two polymers occurred. However, it is clear that the characteristic 
peak of the blend membrane were constantly shifting by changing the 
composition likely due to the secondary interaction between the func­
tional groups of two polymers [20,47]. These interactions indicate no 
phase separation occurs between CHT and PCL in accordance with 
Sarasam et al. [34] and She et al. [38] who observed a negative Flory 
Huggins parameter for these two polymers. 
The penetration depth of AIB-FTIR absorption, dp, for a sample is 
given by the following equation [31]: 
À 
dp =---;:::=== 
21r �sin20 - "21 (4) 
where, À. and 0 are the wavelength and incident angle (30') respec­
tively. Oit is the ratio of refractive index of the sample to that of prism. 
The refractive indices of germanium and polymeric materials are 4.0 
and = 1.5, [31], respectively. By putting the wavenurnbers corre­
sponding to the characteristic absorption, we obtain a penetration 
depth around = 3 µm, which means that the AIB-FTIR spectra could 
only gather the information from first few micrometer depth of the 
surface, whereas the thickness of the membrane sample were around 
80µm. 
The comparison of AIB-FTIR spectra for either side of the same 
blend membrane is presented in Fig. 4(B and C, D). One can note that 
the intensities of specific bands of PCL and CHT are almost the same on 
the both surface of PCL/CHT 90/10 and PCL/CHT 80/20 membrane 
indicating almost homogeneous blend. Whereas, in the case of PCL/ 
CHT 70/30, the CHT characteristic peak were higher on the bottom 
surface indicating probable phase segregation of PCL and CHT through 
the membrane thickness. From this AIB-FTIR study, one can conclude 
no phase separation occurs due to the interaction between PCL and CHT 
but a segregation could occur through the membrane thickness from the 
composition of PCL/CHT 70/30 due to distinguished chemical prop­
erties of the polymer mentioned earlier. 
AIB-FTIR chemical mapping (Fig. 5) of two characteristic bands 
were observed to highlight the difference of the membrane surface 
chemistry; C=O (1726 cm-1) for PCL and intramolecular hydrogen 
bonded N-H and 0-H (3364cm-1) for CHT [21]. 
From the chemical FTIR mapping, on top and bottom surface, we 
can verify tl!at by increasing the concentration of CHT in the blends, the 
absorbance of C = 0 decreases and the absorbance of intramolecular 
hydrogen bonded N-H and 0-H increases [21,48]. In well agreement 
with the Fig. 4 (B, C, D), when the intensities are correlated on both the 
surfaces of the blend, it appears that PCL and CHT have almost the same 
intensities on PCL/CHT 90/0 and 80/20 indicating no macroscopic 
phase separation. Whereas, for the blend PCL/CHT 70/30, CHT wt% 
likely to be higher on the bottom surface than the top surface. More­
over, on the bottom surface of PCL/CHT 70/30, the local concentra­
tions of PCL and CHT at the micrometer scale (i.e. each pixel represents 
a 50 µm x 50 µm of analyzed surface) is seemingly not homogenous as 
CHT zone are complementary of those of PCL indicating a segregation 
of both polymers [34,38,49]. 
3.4. Qystalline and thermal properties 
Crystalline properties of the blend were measured on a 1 cm2 dried 
fiat sheet membrane and depicted in Fig. 6 (A). As an amorphous 
polymer, characteristic broad peak of CHT was hardly observed at 19' 
in PCL/CHT 80/20 and PCL/CHT 70/30. Characteristic intense peaks at 
21.5' and 23.5' at Bragg angles 2-theta corresponding to the (1 1 O) and 
(2 0 O) planes in PCL can be observed. Moreover, by increasing CHT wt. 
%, a slight increase of Bragg angles of the characteristic peak of PCL 
was also observed, indicating an interaction with CHT in agreement 
with the FTIR data [31,50,51]. It could be interesting to correlate this 
data with Honma et al. [31], where the differences in the inter-planar 
spacing of (1 1 O) planes with promoting CHT, the b axes of the PCL 
orthorhombic cell getting more spread out in the cell. Whereas, no 
difference was found in the spaces of the (2 0 O) planes. From these 
results, it can be concluded tl!at significant molecular interaction occurs 
between PCL and CHT during solvent mixing which is quite contra­
















where, subscripts 1 and 2 correspond to CHT and PCL polymer, re-
spectively. To m and To m2 are the equilibrium melting temperature (K)
of the blend and pure PCL (333.15 K) respectively. R is the universal gas
constant (1.98 cal/mol K), ΔH2u is the heat of fusion per mole of 100%
crystalline PCL (3694.67 cal/mol), V2u (99.65 cm3/mol) and V1u
(1546.82 cm3/mol) are molar volumes of the repeating unit of polymers
and Ψ2 refers to the volume fraction of PCL in the blend.
The Nishi-Wang plot (Fig. 7) shows that our experimental data
cannot be represented with a line passing through the origin, indicating
that the interaction parameter (χ12) was composition-dependent and
cannot be a constant value [34]. From where it could be concluded that
like the most cases, in our data, the interaction parameter χ12 was not
playing a decisive role on the melting behaviour of the crystalline-
amorphous polymer systems due to elevation of melting point. This was
termed as ‘experimental verification’ reported by Nishi et al. [58].
3.5. Enzymatic degradation
The enzymatic hydrolysis of polymeric biomaterials is a hetero-
geneous process that is affected by the mode of interaction between the
enzymes and polymer chains. It generally involves four steps: (a) dif-
fusion of the enzyme from the bulk solution to the solid surface, (b)
adsorption of the enzyme on the substrate, forming an en-
zyme–substrate complex, (c) hydrolysis reaction catalyzed by the en-
zyme, forming smaller, soluble polymeric chain and (d) diffusion of the
soluble degradation products from the solid substrate to the solution
[29]. The rate of the overall degradation is controlled by the slowest
step. The effect of enzymatic degradation by lipase in terms of wt. loss
(%) was observed on four batches of samples in Fig. 8 (A). A fast and
almost selective degradation of PCL from all the blends within 48 h was
found. This was because the concentration of lipase (7 U/ml) in the
experiment was higher than the human physiological condition
(0.03–0.190 U/ml) [59–61]. In addition, the enzyme can easily diffuse
through the bulk of porous scaffolds as the size of the bulky protein
chains of the enzymes (> 10 nm) is more than 100 times smaller than
the scaffolds pore size, leading to a faster degradation compared to
dense, non-porous scaffolds.
Contrastingly, when the degradation was conducted without en-
zyme, the degradation of the blend was significantly low (Fig. 8 (C))
[17]. Moreover, Pure PCL showed the lowest degradation and the de-
gradation increases by increasing the CHT wt.%.
The mechanisms leading to the degradation of the PCL and CHT
polymers are significantly different. Generally, PCL, like polyester,
degrades similarly to lipid hydrolysis, which is highly facilitated by
lipase (lipidase) like enzyme. Lipases are water-soluble enzymes that
hydrolyze ester bonds of water-soluble substrates such as triglycerides,
phospholipids, and cholesteryl esters [62]. Increasing the CHT wt.% (or
decreasing PCL wt.%) not only increases the hydrophilicity but also
increases the macrovoids size. As a result the porous bulk of scaffolds
was more accessible by the enzymatic solution leading to faster de-
gradation via formation of a smaller soluble enzyme–substrate complex
[63]. On the other hand, CHT, like polysaccharide, consisting of N-
acetyl/deacetyl glucosamine, degrades by oxidative-reductive chain
scission and lipase has very weak effect on CHT degradation [64–67]. In
case of degradation without enzyme, the ability of the material to swell
by absorbing water [68], which was increasing by increasing CHT wt.
%, plays a key role for the degradation.
The surface morphology of degraded membrane after different time
intervals is presented in the Fig. 9. In case of degradation assay with
enzyme, a noticeable damage on the surface of membranes were ob-
served with a significant weight loss.
The change in pH measured in the degraded solution is reported in
the Fig. 8 (B). PCL/CHT 100/0 has shown the lowest pH probably due
to the presence of higher amount of acidic residue via ester chain de-
gradation. Overall in all the blends, the pH remained very close to the
physiological pH (7.4), indicating almost no toxicity of the degraded
solution.
3.6. Microscopic PCL/CHT chemical structure
The presence of secondary interactions between PCL and CHT was
observed above in the FTIR as well as in the crystallinity (with a shift of
the characteristic peaks) that allow avoiding phase separation and total
immiscibility between the two polymers.
The solvent and non-solvent power can be evaluated through the
interaction distances using the Hansen solubility parameter approach
[69]. From the Table 2, the interaction distances are found lowest be-
tween PCL and the acids (FA/AA), indicating the acids are good sol-
vents for PCL whereas water is a non-solvent with highest interaction
distance. On the other hand, the interaction distances between CHT and
the acids (FA/AA) was found high (with almost the same non-solvent
power), indicating the acids are not good solvent for CHT. However, the
solubility of CHT in water at low pH as well as in concentrated acids is
usually observed due to strong acid/base interaction, turning CHT to a
polyelectrolyte via protonation of amine groups. The use of NaOH so-
lution as a non-solvent is then crucial, as the base will deprotonate the
amine groups leading to insoluble CHT. Thus, NaOH solution is a
stronger non-solvent of CHT than pure water.
Thus the phase segregation phenomena along the membrane
thickness with high CHT wt% (apparently in PCL/CHT 70/30 in our
case) can be explained (Fig. 10.) by the presence of a NaOH conc.
gradient along the thickness of the polymer solution (i.e. high NaOH
conc. at the top to low NaOH conc. at the bottom) during the phase
inversion process. The NaOH conc. gradient was created along the
thickness of the polymer solution due to faster neutralization at the top
surface than at the bottom surface, leading to the formation of con-
jugate bases (FA− and AA−, which are non-solvent too). The presence
earlier [52]. It was also reported that by increasing the CHT wt%, the 
intensity of the characteristic peak of PCL should decrease as the con-
jugation with PCL and CHT chains suppresses the crystallization of PCL 
[31,53–55]. Unlike the other reported data, in our case, this effect was 
not observed and we found a considerable increase of intensity of the 
PCL specific peak in the blend by increasing CHT wt.%.
Apart from the characteristic peaks of PCL and CHT, some other 
intense peaks were also detected due to the formation of different type 
of crystals with different D spacing within the crystal lattice [51]. Those 
gave an overall crystalline behaviour to the blend. Although in case of 
PCL/CHT 70/30, those peaks were almost disappear due to significant 
amorphousness induced by CHT.
DSC analysis Fig. 6 (B) were also performed on the same batch of 
the sample. Generally, higher a polymer material will have crystallinity, 
higher energy should be required to break the crystal, hence higher will 
be the temperature of melting (Tm). In our case by increasing CHT wt%
the temperature of melting (Tm) of the blend was increasing whereas in 
case of P CL/CHT 70/30 it was decreasing. This phenomena can be 
correlated with the crystallinity of the blend as discussed above [21].
Generally, pure PCL melts at 60 °C, whereas CHT undergoes thermal 
degradation at around 270 °C prior to melting [21]. It is still difficult to 
determine the glass transition (Tg) of CHT by conventional thermal 
technique, although some efforts have been done [52,56,57]. Thus, the 
variation of the melting point of PCL in the blend was monitored by 
varying the composition of CHT. Unlike other reported data 
[21,31,32,35], we found that by increasing CHT wt%, Tm of the blend 
increased [51] except PCL/CHT 70/30.
The interaction between the two polymers can be analyzed through 
the Flory-Huggins interaction parameter (χ12) to correlate temperature 
of melting and volume fraction of PCL. The equation is evaluated from 
the simplified Nishi-Wang equation [34,58] for high MW crystalline-
amorphous polymer system as follows:
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of conjugate bases increased the gradient of solvent activity. CHT
chains have more affinity for the solvent (FA/AA) than PCL and thus the
gradient of chemical potential for CHT is more important than PCL
[73]. Due to these differences in chemical potential gradient, CHT
should move towards the bottom surface to some extent higher than
PCL chains. Whereas PCL chains coagulated on the top surface faster
than CHT as water is a strong non solvent of PCL. The PCL chains will
be trapped in contact with water and cannot move anymore.
3.7. Mesoscopic morphological structuration of the membrane
The equilibrium phase diagram for the ternary system of polymer-
solvent-nonsolvent, Fig. 11 (A), can be used to understand the route
taken during the membrane precipitation process, leading to the for-
mation of double porosity. Any point within the triangle represents a
mixture of three components where the system composed of two
phases: a one-phase region, where all components are miscible, and a
two-phase region, where the system separates into high viscosity
(polymer-rich) and low viscosity (polymer-poor) phases. The liquid-li-
quid phase boundary is the so-called binodal curve. Every composition
inside the binodal curve will demix into two liquid phases which differ
in composition but are thermodynamically in equilibrium with each
other. The tie line connects a pair of equilibrium compositions in the
phase diagram. Thus, at low polymer concentrations where the tie line
intersects the binodal, the system is a low viscosity polymer-poor phase.
As the concentration of polymer is increased, the viscosity of the system
also increases rapidly and the tie line intersects the binodal at high
polymer concentration, consider as the gelation point (E), a highly
viscous polymer-rich phase that further polymer chain movement is not
possible [74,75].
Two extreme cases can be considered according to the PCL/CHT
percentage ratio: Case 1 (left column in Fig. 11.) corresponds to the
pure PCL blend and case 2 (right column in Fig. 11.) corresponds to the
PCL/CHT blend with lower polymer percentage. As previously dis-
cussed, one difference between these cases is the use of higher NaOH
solution in the non-solvent phase for higher CHT concentration. In the
last case, the gelation point should occur for higher polymer con-
centration, as there is less attractive interaction between CHT and
solvent in basic solution.
Regarding the triangular phase diagram (Fig. 11 (A)), the entire
membrane formation process follows the path (A-B-C-D), where A re-
presents the initial casted solution when it is just immersed inside the
non-solvent (t= 0), B represents the demixing point where the two
liquid phases formation start. As the two-phase formation proceed,
more solvent was neutralized by increasing the viscosity of the
polymer-rich phase. At one point, the viscosity is high enough to restrict
further polymer chain movement and the polymer is considered as
solid, representing the solidification point C, where it intersects the tie
line with the gelation point E. From B to C, the polymer lean phase
coalesces to form the observed macrovoid: the extent of the coalescence
depends of the time need to go from B to C.
After that, the membrane structure does not evolve and further
solvent exchange results in the removal of solvent. Some shrinkage of
the bulk volume could also occurs leading to the final membrane
structure D [74,76]. The composition D is in equilibrium between the
polymer-rich and polymer-poor phase and the position of point D on the
polymer/non-solvent line of the phase diagram determines the overall
porosity of the membrane.
Due to the presence of the track-etched membrane on the casted
solution, just after immersion, the non-solvent has a restricted access to
the polymer solution through the pore of the track-etched membrane,
initiating a spatially heterogeneous solvent-nonsolvent exchange
[30,77]. The phase inversion starts in the zone where there is a direct
contact between the polymer and the non-solvent, resulting the initia-
tion and growth of a liquid wall (nascent macrovoids). The liquid wall,
created from the phase inversion, expands radially from the non-solvent
invasion point (polymer-poor phase) towards the bulk (polymer-rich
phase). During the phase inversion, the polymer concentration of the
liquid wall increases until the solidification point C and thus further
polymer chain movement stops [74,76].
The polymer blend composition, polymer wt.% and non-solvent
concentration play an influential role on the macrovoid size and on the
membrane porosity. Particularly in the case 2, where CHT is present
along with PCL inside the polymer solution, the blend has a higher
affinity with solvents than PCL alone. This is due to higher secondary
interaction between the CHT functional groups and solvents, higher
M.W and the presence of cyclic structure, resulting deployment and
high entanglement of CHT chains in the solution [40]. In that case and
after the demixing point, the non-solvent first has to disable those
δ δ d δ p δ h Interaction distance
(MPa1/2)
Ref.
MPa1/2 MPa1/2 MPa1/2 MPa1/2 PCL CHT
CHT 38,8 22,9 16,6 26,6 23,9 – [70,71]
PCL 20,3 17,7 6,2 7,8 – 23,9 [72]
water 47,8 15,5 16 42,3 36,1 21,6 [69]
FA 22,6 14,6 10 14 9,6 21,9 [69]
AA 21,4 14,5 8 13,5 8,8 23,0 [69]
Fig. 10. Qualitative representation of
the gradient along the thickness and
the differential migration of PCL (in
blue) and CHT (in red) in the blend
after phase inversion (where PCL is
polycaprolactone, CHT is chitosan, FA
is formic acid, AA is acetic acid, FA− is
formate anion and AA− acetate anion
respectively). (For interpretation of the
references to color in this figure legend,
the reader is referred to the Web ver-
sion of this article.)
Table 2
Hansen solubility parameter of CHT, P CL and solvents and the interaction 
distance. All values are given in MPa1/2.
10
secondary interaction between CHT and solvents followed by solvent
exchange via acid-base reaction, leading to a delay in solidification
(t= t2, path B–C). Meantime, more non-solvent invades due to a higher
non-solvent concentration and lower polymer wt.% (in the case of PCL/
CHT 70/30 with 10wt%). As a results further expansion of the liquid
wall take place and eventually two neighboring nascent liquid walls
coalesce before reaching the solidification point C, leading to the for-
mation of larger macrovoids [74,76]. In case 1, due to the presence of
PCL alone, after the demixing point, the solvent exchange starts readily
as, unlike CHT, PCL does not have strong affinity with the solvents. In
addition, due to the lower nonsolvent concentration and higher
polymer wt.% (PCL/CHT 100/0 with 15wt%), the liquid wall reaches
the solidification point C (t= t1; where t1< t2) before significant ex-
pansion, resulting in smaller macrovoids.
A secondary solvent exchange followed by phase inversion also
occurs through the whole volume of the polymer solution because of
the slow diffusion of the non-solvent through the newly formed mac-
rovoids. The polymer solution area, which is protected from direct
exposure from the non-solvent due to the presence of the track-etched
membrane, undergoes the secondary solvent exchange. This phase in-
version takes place at a slower rate and leads to the formation of a
uniform spongy microporous network connected by the macrovoids
[30,74,76,77].
Remigy et al. [76] and, earlier, Strathmann et al. [74] reported that,
due to the heterogeneous and restricted solvent diffusion, the genera-
tion of macrovoid can also be achieved by a dense skin formation on the
polymer solution layer via rapid homogeneous precipitation. In that
case, after formation of the dense skin, it disrupts by shrinkage of the
homogeneous solid layer and the macrovoid formation starts from the
disruption point due to the heterogeneous and restricted access of the
non-solvent. In the present work, we cover the polymer solution with
track-etched membrane, which acts as a dense skin with restricted ac-
cess of the non-solvent [30,77]. The use of track-etched membrane and
its removal allows the generation of largely open macrovoids, which
were not obtained using the classical phase inversion technique. When
no track-etched membrane was used, the membrane material presented
single porosity like conventional liquid-liquid homogeneous phase in-
version and pores were not open enough towards the top surface
(Fig. 3. I, J).
3.8. Cellular compatibility study by LSCM
The cellular compatibility of the four batch of membranes were
observed in confocal images (Fig. 12) at 20× and 60× magnification
after 3 days of seeding HUVECs. The cell nucleus were stained by DAPI
in blue and the actin stress fibers were stained by Phalloidin Alexa
Fluor™ 488 in green. The scaffolds were designed to develop as bioac-
tive scaffolds for a tissue engineered vascular grafts to obtain higher
endothelial performance by the HUVECs by tuning the physico-che-
mical and morphological properties of the blends. At 20× magnifica-
tion all the membranes are showing a very high number of cells adhered
on the membrane. By introducing CHT, all the PCL/CHT blend are
showing even higher number of cell-cell and cell-scaffolds interaction
than only pure PCL membrane and make an almost confluent
Fig. 11. (A). Schematic phase diagram of the system polymer-solvent-nonsolvent representing the membrane macrovoids formation pathway (A-B-C-D), (B).
Illustrative representation of the formation of macrovoids. Case 1: formation of smaller macrovoids consisting of polymer as PCL, solvent as FA/AA and non-solvent
as NaOH at low concentration and Case 2: formation of bigger macrovoids consisting of polymer as PCL + CHT, solvent as FA/AA and non-solvent as NaOH at high
concentration (where PCL is polycaprolactone, CHT is chitosan, FA is formic acid, AA is acetic acid respectively).
monolayer within 3 days. In 60× magnification, we discover that the
HUVECs maintain their natural endothelial like morphology by strongly
expressing the actin fibers in green, which was significantly visible in
PCL/CHT 80/20 and 70/30 blend. These findings clearly suggest that
all four batches of scaffolds are highly biocompatible, especially by
introducing CHT, likely because of better hydrophilicity, pore spacing
and morphology. Du et al. [22] reported rapid HUVECs adhesion and
proliferation upon gradient PCL/CHT nanofibrous, electrospun scaf-
folds than the uniform one due to higher adsorption of VEGF on the
CHT rich side (luminal side). Casillo et al. [78] grew endothelial cells
on non-porous and porous SiO2 membranes where they find higher cell-
matrix adhesion on the surface with bigger pores probably because the
spacing between the pores, and thus the amount of continuous space for
the cells to adhere was higher.
The exclusive cellular characterization of these double porous ma-
terials was extensively carried out and already reported in previous
papers [44,45]. Static cell culture with human mesenchymal stem cells
(hMSCs) has been performed for 3 weeks. With confocal images, it was
shown that these materials have a good ability to promote cellular in-
vasion and proliferation by increasing CHT wt% [44]. The additional
cellular resistance has also been monitored by seeding human umbilical
vein endothelial cells (HUVECs) on the membranes embedded inside a
microfluidic organ-on-chip system by mimicking dynamic physiological
condition. Here again the results suggest that by increasing CHT wt%,
the microstructural and chemical properties were significantly im-
proved resulting in enhanced hydraulic resistance due to increased
cellular barrier function [45].
Significant advancement has been made in engineered blood vessels
grafts with development of bioscaffolds constructs, providing an alter-
native to replace the damaged vessel in treating cardiovascular diseases
(CVD). The successful implementation of these two kind of cells in our
studies could be strategically useful to regenerate small diameter blood
vascular system. Human endothelial cells (ECs) can be seeded on the
surface of the 3D scaffold (on the luminal side). Whereas seeding the
mesenchymal stem cells (MSCs) inside the bulk could be obvious due to
two beneficial properties. MSCs could be genetically modified to pro-
duce the essential vascular endothelial growth factors (VEGFs) in order
to enhance the endothelium [79–81], which is very important, as the
damaged endothelium could not produce the VEGFs naturally [82].
MSCs proliferation and viability are highly dependent on environ-
mental cues like material stiffness, growth medium and other physical
and mechanical forces [83,84]. With proper environmental condition,
MSCs can change their phenotype to smooth muscle cells, which are
usually present inside the vessels underneath the endothelium [85–87].
As the cell will grow, the biodegradable scaffold will be gradually re-
placed by cells and, at the end, the scaffold will be completely absorbed
inside the body to achieve the blood vessel construct.
4. Conclusions
A PCL/CHT membrane with a unique double porosity level has been
developed for tissue engineering applications. The membrane has been
fabricated with a modified phase inversion technique from different
ratios of PCL/CHT polymer blends. Macrovoids at the membrane sur-
face have been formed which are connected through membrane mi-
croporous network. The physico-chemical properties and morpholo-
gical structure of the membrane have been characterized and the
mechanisms at the origin of the membrane formation have been dis-
cussed. This membrane exhibits interesting functionalities for tissue
engineering applications:
- The membrane possesses a structure with three dimensional double
porosity level, thanks to the micro-patterning techniques. The SEM
images show that plenty of micrometers macrovoids (20–90 μm) are
connected through spongy porous network.
- The morphological analysis of the membrane shows that the mac-
rovoids size increased by increasing the Chitosan concentration.
ATR-FTIR chemical spectra confirm the presence of secondary in-
teraction between PCL and Chitosan. From the FTIR chemical
mapping, we found a slight segregation of polymers along the
thickness in case of high Chitosan wt.%. From the XRD and DSC
studies, we observed an increase of the crystallinity and melting
point by increasing CHT wt.%.
- The biodegradability of the material can be adjusted according to
the PCL/CHT ratio. The enzymatic degradation of the PCL/CHT
double porous scaffold using lipase (from P. cepacia), pointed out a
faster and almost selective degradation of PCL in the blend.
- Human umbilical vein endothelial cells (HUVECs) show rapid cell
adhesion and proliferation on the membranes, especially by in-
troducing chitosan in the blend, by maintaining their natural cel-
lular morphology. PCL/CHT materials allows then to act as a niche
to host cells. Such a structure could ensure biofunctionality for
tissue repair: where the macrovoids could be useful for three-di-
mensional cell culture and spongy microporous network could be
useful to transport essential nutrients, growth factors and oxygen for
cell survival.
The encouraging data obtained in this work demonstrate that these
Fig. 12. LSCM images of HUVECs on PCL/CHT membrane after 3 days with
staining (nucleus by DAPI in blue and cell cytoskeleton by phalloidin in green).
Scale bar: 100 μm in 15×mag. and 50 μm 60×mag. respectively. (For in-
terpretation of the references to color in this figure legend, the reader is referred
to the Web version of this article.)
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